-
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
-
ISS, Glass Lewis, and Egan-Jones Recommend that Acorda Stockholders Vote FOR the Proposal to Implement a Reverse Stock Split
-
Acorda Therapeutics (ACOR) Withdraws Proposal to Increase Authorized Shares
-
Acorda Therapeutics Withdraws Proposal to Increase Authorized Shares from Special Meeting of Stockholders
-
ACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 22 MARCH 2016
-
Acorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share U
-
ACORDA SUPPLEMENTS THE TENDER OFFER DOCUMENT RELATING TO THE VOLUNTARY PUBLIC TENDER OFFER ON 18 MARCH 2016
-
Acorda Therapeutics Supplements Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units
-
THE FINNISH FINANCIAL SUPERVISORY AUTHORITY HAS APPROVED THE TENDER OFFER DOCUMENT, ACORDA WILL COMMENCE THE VOLUNTARY PUBLIC TENDER OFFER ON 11 MARCH 2016
-
Acorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Th
-
Morning Movers 5/6: SBGI, ACOR, ARM, LINC, MPG Higher; ABD, ACAS, ALY, BBND, DENN Lower
-
Unusual 11 Mid-Day Movers 3/31: PLD, CDII, JTX, AMLN Higher; RIV, ACOR, LEN, GM Lower
-
Acorda Therapeutics (ACOR) Provides '09 Business and Pipeline Update

